[1]
|
Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary[J]. Proc Am Thorac Soc, 2011, 8: 381-385. doi: 10.1513/pats.201107-042ST |
[2]
|
Gaeta M, Ascenti G, Mazziotti S, et al. MRI differentiation of pneumonia-like mucinous adenocarcinoma and infectious pneumonia[J]. Eur J Radiol, 2012, 81: 3587-3591. doi: 10.1016/j.ejrad.2011.12.022 |
[3]
|
Masai K, Sakurai H, Suzuki S, et al. Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases[J]. J Surg Oncol, 2016, 114: 211-215. doi: 10.1002/jso.24302 |
[4]
|
Kalkanis A, Palaiodimos L, Klinaki I, et al. (18)F-FDG PET/CT Imaging of Pulmonary Mucinous Cystadenocarcinoma with Signet Ring Cells[J]. Nucl Med Mol Imaging, 2017, 51: 277-280. doi: 10.1007/s13139-016-0402-4 |
[5]
|
包盈莹, 雷永霞, 李新春, 等. 肺浸润性黏液腺癌的CT及18F-FDG PET/CT表现[J]. 中国医学影像学杂志, 2019, 27: 815-819. doi: 10.3969/j.issn.1005-5185.2019.11.005
Bao YY, Lei YX, Li XC, et al. CT and 18F-FDG PET/CT Features of Pulmonary Invasive Mucinous Adenocarcinoma[J]. Zhongguo Yixue Yingxiangxue Zazhi, 2019, 27: 815-819. doi: 10.3969/j.issn.1005-5185.2019.11.005 |
[6]
|
Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression[J]. Am J Surg Pathol, 2004, 28: 442-452. doi: 10.1097/00000478-200404000-00003 |
[7]
|
Chung JH, Choe G, Jheon S, et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread[J]. J Thorac Oncol, 2009, 4: 1490-1495. doi: 10.1097/JTO.0b013e3181bc9731 |
[8]
|
Pelosi G. The new taxonomy of lung adenocarcinoma stemming from a multidisciplinary integrated approach: novel pathology concepts and perspectives[J]. J Thorac Oncol, 2011, 6: 241-243. doi: 10.1097/JTO.0b013e31820bfcba |
[9]
|
Er TK, Lin CW, Liu TC, et al. Increase EGFR Mutations Detection Rate in Lung Adenocarcinoma by Real-Time PCR Screening Followed by Direct Sequencing[J]. Appl Immunohistochem Mol Morphol, 2015, 23: 343-348. doi: 10.1097/PDM.0000000000000037 |
[10]
|
王迪, 于红. 肺黏液腺癌的影像学与病理学研究进展[J]. 国际医学放射性杂志, 2012, 35: 426-429. https://www.cnki.com.cn/Article/CJFDTOTAL-GWLC201205009.htm
Wang D, Yu H. Imaging and pathological progress in pulmonary mucinous adenocacinoma[J]. Guoji Yixue Fang shexing Zazhi, 2012, 35: 426-429. https://www.cnki.com.cn/Article/CJFDTOTAL-GWLC201205009.htm |
[11]
|
Shah RM, Friedman AC. CT angiogram sign: incidence and significance in lobar consolidations evaluated by contrast-enhanced CT[J]. AJR Am J Roentgenol, 1998, 170: 719-721. doi: 10.2214/ajr.170.3.9490960 |
[12]
|
雷永霞, 李新春, 包盈莹, 等. 炎症型肺浸润性黏液腺癌CT表现[J]. 中国医学影像技术, 2020, 36: 1027-1030. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX202007021.htm
Lei YX, Li XC, Bao YY. CT features of pneumonic-type pulmonary invasive mucinous adenocarcinoma[J]. Zhongguo Yixue Yingxiang Jishu, 2020, 36: 1027-1030. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX202007021.htm |
[13]
|
Shimizu K, Okita R, Saisho S, et al. Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings[J]. Onco Targets Ther, 2017, 10: 153-163. |
[14]
|
Wang Z, Yu M, Chen Y, et al. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report[J]. J Med Case Rep, 2017, 11: 202. doi: 10.1186/s13256-017-1380-6 |
[15]
|
Sawada E, Nambu A, Motosugi U, et al. Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings[J]. Jpn J Radiol, 2010, 28: 251-258. doi: 10.1007/s11604-009-0414-4 |
[16]
|
Aquino SL, Halpern EF, Kuester LB, et al. FDG-PET and CT features of non-small cell lung cancer based on tumor type[J]. Int J Mol Med, 2007, 19: 495-499. |
[17]
|
Murakami S, Saito H, Karino F, et al. 18F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma[J]. Eur J Radiol, 2013, 82: e721-e725. doi: 10.1016/j.ejrad.2013.07.028 |
[18]
|
Lee HY, Lee KS, Han J, et al. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcino-ma: CT and FDG PET findings and pathologic comparisons[J]. Lung Cancer, 2009, 65: 170-175. doi: 10.1016/j.lungcan.2008.11.009 |
[19]
|
Shim SS, Han J. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation[J]. Ann Nucl Med, 2010, 24: 357-362. doi: 10.1007/s12149-010-0358-x |
[20]
|
Chang JM, Lee HJ, Goo JM, et al. False positive and false negative FDG-PET scans in various thoracic diseases[J]. Korean J Radiol, 2006, 7: 57-69. doi: 10.3348/kjr.2006.7.1.57 |
[21]
|
Cha MJ, Lee KS, Kim TJ, et al. Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign[J]. Korean J Radiol, 2019, 20: 513-521. doi: 10.3348/kjr.2018.0409 |
[22]
|
Tsubakimoto M, Yamashiro T, Tamashiro Y, et al. Quantitative CT density histogram values and standardized uptake values of FDC-PET/CT with respiratory gating can distinguish solid adenocarcinomas from squamous cell carcinomas of the lung[J]. Eur J Radiol, 2018, 100: 108-115. doi: 10.1016/j.ejrad.2018.01.021 |